Abstract
Cabozantinib (Cabo) in advanced non-clear cell renal cell carcinoma (nccRCC): A retrospective multicenter analysis
Journal of clinical oncology, Vol.36(15_suppl), pp.4579-4579
05/20/2018
DOI: 10.1200/JCO.2018.36.15_suppl.4579
Abstract
Abstract only
Details
- Title: Subtitle
- Cabozantinib (Cabo) in advanced non-clear cell renal cell carcinoma (nccRCC): A retrospective multicenter analysis
- Creators
- Nieves Martinez Chanza - Dana-Farber Cancer InstituteDominick Bossé - Ottawa HospitalMehmet Asim Bilen - The University of Texas MD Anderson Cancer CenterDaniel M. Geynisman - Fox Chase Cancer CenterArchana Balakrishnan - Michigan State UniversityRohit K. Jain - University of BaltimoreI. Alex Bowman - The University of Texas Southwestern Medical CenterYousef Zakharia - University of IowaVivek Narayan - Penn Center for AIDS ResearchBenoit Beuselinck - KU LeuvenNeeraj Agarwal - University of UtahRana R. McKay - University of California San DiegoJoann Hsu - City Of Hope National Medical CenterSumit Shah - University of San FranciscoAbhishek Tripathi - Oklahoma State University Oklahoma CityElaine Tat Lam - University of Colorado DenverTracy Lynn Rose - University of North Carolina HospitalsBenedito A. Carneiro - Northwestern UniversityNicholas J. Vogelzang - Comprehensive Cancer Centers of NevadaLauren Christine Harshman - Dana-Farber Cancer Institute
- Resource Type
- Abstract
- Publication Details
- Journal of clinical oncology, Vol.36(15_suppl), pp.4579-4579
- DOI
- 10.1200/JCO.2018.36.15_suppl.4579
- ISSN
- 0732-183X
- eISSN
- 1527-7755
- Language
- English
- Date published
- 05/20/2018
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984548378702771
Metrics
11 Record Views